Crossmark

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Crossref DOI link: https://doi.org/10.1007/s00125-022-05787-2

Published Online: 2022-09-24

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Davies, Melanie J. https://orcid.org/0000-0002-9987-9371
Aroda, Vanita R. https://orcid.org/0000-0002-7706-4585
Collins, Billy S. https://orcid.org/0000-0002-5271-3534
Gabbay, Robert A. https://orcid.org/0000-0003-3541-1486
Green, Jennifer https://orcid.org/0000-0002-5061-9632
Maruthur, Nisa M. https://orcid.org/0000-0002-5799-104X
Rosas, Sylvia E. https://orcid.org/0000-0002-9903-4002
Del Prato, Stefano https://orcid.org/0000-0002-5388-0270
Mathieu, Chantal https://orcid.org/0000-0002-4055-5233
Mingrone, Geltrude https://orcid.org/0000-0003-2021-528X
Rossing, Peter https://orcid.org/0000-0002-1531-4294
Tankova, Tsvetalina https://orcid.org/0000-0002-7572-1131
Tsapas, Apostolos https://orcid.org/0000-0003-0221-4072
Buse, John B. https://orcid.org/0000-0002-9723-3876
License Information

Text and Data Mining valid from 2022-09-24

Version of Record valid from 2022-09-24
More Information

Article History

Received: 2 August 2022

Accepted: 18 August 2022

First Online: 24 September 2022

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below